ArticleMolecular therapy. Methods & clinical development2021

Nonconditioned ADA-SCID gene therapy reveals ADA requirement in the hematopoietic system and clonal dominance of vector-marked clones.

Toru Uchiyama et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.